UDG.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 saus. 1970 @ 03:00):

Stats
Šios dienos apimtis	3.14M
Vidutinė apimtis	2.82M
Rinkos kapitalizacija	0.00
EPS	£0.0573 ( 2019-06-29 )
Last Dividend	£0.125 ( 2021-01-07 )
Next Dividend	£0 ( N/A )
P/E	0.420
ATR14	£0 (0.00%)

UDG Healthcare plc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

UDG Healthcare plc Finansinės ataskaitos

Annual	2020
Pajamos:	£1.28B
Bruto pelnas:	£394.83M (30.87 %)
EPS:	£0.373

FY	2020
Pajamos:	£1.28B
Bruto pelnas:	£394.83M (30.87 %)
EPS:	£0.373

FY	2019
Pajamos:	£1.30B
Bruto pelnas:	£371.14M (28.58 %)
EPS:	£0.231

FY	2018
Pajamos:	£1.32B
Bruto pelnas:	£381.60M (29.02 %)
EPS:	£0.0153

Financial Reports:

No articles found.

UDG Healthcare plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

UDG Healthcare plc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.26 - Potential for dividend initiation, but uncertain (5.23%)

Information

First Dividend	£0.00468	1990-01-29
Last Dividend	£0.125	2021-01-07
Next Dividend	£0	N/A
Payout Date	2021-02-05
Next Payout Date	N/A
# dividends	63	--
Total Paid Out	£1.931	--
Avg. Dividend % Per Year	0.00%	--
Score	4.03	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.26
Div. Directional Score	8.01	--

Next Divdend (Est)
(2024-06-21)

£0 Estimate 0.00 %

Dividend Stability

0.09 Very Bad

Dividend Score

4.03

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
1990	£0	0.00%
1991	£0	0.00%
1992	£0	0.00%
1993	£0	0.00%
1994	£0	0.00%
1995	£0	0.00%
1996	£0	0.00%
1997	£0	0.00%
1998	£0	0.00%
1999	£0	0.00%
2000	£0	0.00%
2001	£0	0.00%
2002	£0	0.00%
2003	£0	0.00%
2004	£0	0.00%
2005	£0	0.00%
2006	£0	0.00%
2007	£0	0.00%
2008	£0	0.00%
2009	£0	0.00%
2010	£0	0.00%
2011	£0	0.00%
2012	£0	0.00%
2013	£0	0.00%
2014	£0	0.00%
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£0	0.00%
2019	£0	0.00%
2020	£0.168	0.02%
2021	£0.125	0.02%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SEQI.L	Dividend Knight	2023-07-27	Quarterly	10	3.85%
ICGC.L	Dividend Knight	2023-09-14	Annually	15	1.80%
BISI.L	Dividend Knight	2024-01-04	Annually	32	2.05%
WTB.L	Dividend Knight	2023-05-25	Annually	33	0.87%
NTV.L	Dividend Knight	2023-07-20	Semi-Annually	25	4.03%
EMG.L	Dividend King	2023-08-10	Semi-Annually	31	3.60%
SPT.L	Dividend Knight	2023-08-10	Semi-Annually	32	1.51%
JD.L	Dividend Knight	2023-12-07	Annually	28	0.21%
BUT.L	Dividend King	2023-08-03	Quarterly	49	1.28%
PNL.L	Dividend Knight	2023-08-24	Quarterly	41	0.75%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0726	1.500	8.55	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0526	1.200	8.25	9.90	[0 - 0.3]
returnOnEquityTTM	0.0986	1.500	-0.0160	-0.0240	[0.1 - 1]
payoutRatioTTM	0.453	-1.000	5.47	-5.47	[0 - 1]
currentRatioTTM	1.919	0.800	5.41	4.32	[1 - 3]
quickRatioTTM	0.791	0.800	-0.0553	-0.0442	[0.8 - 2.5]
cashRatioTTM	0.791	1.500	6.72	10.00	[0.2 - 2]
debtRatioTTM	0.167	-1.500	7.22	-10.00	[0 - 0.6]
interestCoverageTTM	8.87	1.000	7.83	7.83	[3 - 30]
operatingCashFlowPerShareTTM	0.926	2.00	9.69	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.774	2.00	9.61	10.00	[0 - 20]
debtEquityRatioTTM	0.299	-1.500	8.81	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.309	1.000	8.19	8.19	[0.2 - 0.8]
operatingProfitMarginTTM	0.0995	1.000	-0.0102	-0.0102	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.785	1.000	6.75	6.75	[0.2 - 2]
assetTurnoverTTM	0.725	0.800	8.50	6.80	[0.5 - 2]
Total Score				10.75

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.18	1.000	6.45	0	[1 - 100]
returnOnEquityTTM	0.0986	2.50	-0.0103	-0.0240	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.774	2.00	9.74	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.926	2.00	9.69	10.00	[0 - 30]
payoutRatioTTM	0.453	1.500	5.47	-5.47	[0 - 1]
pegRatioTTM	47.57	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.180	1.000	7.99	0	[0.1 - 0.5]
Total Score				5.26

UDG Healthcare plc

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, the Republic of Ireland.